Penile Prosthesis in Patients With Erectile Dysfunction
Not Applicable
Recruiting
- Conditions
- Erectile Dysfunction
- Registration Number
- NCT03466619
- Lead Sponsor
- Tanta University
- Brief Summary
Erectile dysfunction (ED) is defined as the persistent inability to attain and or maintain an erection sufficient to permit satisfactory sexual performance
- Detailed Description
In the literature, well- designed studies evaluating safety and efficacy of inflatable penile prosthesis (IPP) is lacking. So, this series aimed at investigating this prospectively.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
- Patients complaining of ED with contraindication or failure of medical treatment
Exclusion Criteria
- Patients lacking manual dexterity or mental abilities necessary to operate the pump
- General contraindications as uncorrectable bleeding tendency
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of patients with improved erectile dysfunction 3 years The number of patients with improved erectile dysfunction
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are affected by inflatable penile prosthesis (IPP) implantation in ED patients compared to PDE5 inhibitors?
How does the safety profile of inflatable penile prosthesis (IPP) compare to vacuum erection devices and injectable therapies in ED management?
Which biomarkers predict optimal outcomes for inflatable penile prosthesis (IPP) in patients with vasculogenic versus psychogenic erectile dysfunction?
What are the long-term adverse events associated with inflatable penile prosthesis (IPP) and their management strategies in clinical practice?
How does inflatable penile prosthesis (IPP) integrate with phosphodiesterase type 5 (PDE5) inhibitors in multimodal treatment approaches for ED?
Trial Locations
- Locations (1)
Tanta university - faculty of medicine
🇪🇬Cairo, Elgharbia, Egypt
Tanta university - faculty of medicine🇪🇬Cairo, Elgharbia, EgyptSherief Abdelsalam, lecturerContact00201095159522Sheriefabdelsalam@yahoo.com